abt-199 and Leukemia--Prolymphocytic

abt-199 has been researched along with Leukemia--Prolymphocytic* in 5 studies

Other Studies

5 other study(ies) available for abt-199 and Leukemia--Prolymphocytic

Article	Year
Partial response to venetoclax and ruxolitinib combination in a case of refractory T-prolymphocytic leukemia. Hematology (Amsterdam, Netherlands), 2023, Volume: 28, Issue:1 Topics: Humans; Leukemia, Prolymphocytic; Leukemia, Prolymphocytic, T-Cell; Male; Middle Aged; Nitriles; Pyrimidines	2023
Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia. Haematologica, 2021, 08-01, Volume: 106, Issue:8 Topics: Adenine; Bridged Bicyclo Compounds, Heterocyclic; Humans; Leukemia, Prolymphocytic; Piperidines; Sulfonamides	2021
First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL). Leukemia & lymphoma, 2020, Volume: 61, Issue:2 Topics: Bridged Bicyclo Compounds, Heterocyclic; Humans; Leukemia, Prolymphocytic; Leukemia, Prolymphocytic, T-Cell; Pentostatin; Sulfonamides; T-Lymphocytes	2020
B-cell prolymphocytic leukemia successfully treated with B-cell receptor antagonists, but resistant to venetoclax. Leukemia & lymphoma, 2020, Volume: 61, Issue:3 Topics: Bridged Bicyclo Compounds, Heterocyclic; Humans; Leukemia, Prolymphocytic; Leukemia, Prolymphocytic, B-Cell; Receptors, Antigen, B-Cell; Sulfonamides	2020
Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma. Acta oncologica (Stockholm, Sweden), 2020, Volume: 59, Issue:12 Topics: Adult; Alemtuzumab; Bridged Bicyclo Compounds, Heterocyclic; Epigenesis, Genetic; Humans; Leukemia, Prolymphocytic; Leukemia, Prolymphocytic, T-Cell; Lymphoma; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sulfonamides; T-Lymphocytes	2020